Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Zynex, Inc.    ZYXI

ZYNEX, INC.

(ZYXI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/22/2020 09/23/2020 09/24/2020 09/25/2020 09/28/2020 Date
17.18(c) 16.69(c) 15.93(c) 16.7(c) 16.9(c) Last
417 719 468 949 323 517 268 316 390 394 Volume
+6.44% -2.85% -4.55% +4.83% +1.20% Change
More quotes
Financials (USD)
Sales 2020 83,7 M - -
Net income 2020 11,5 M - -
Net Debt 2020 - - -
P/E ratio 2020 50,9x
Yield 2020 -
Sales 2021 150 M - -
Net income 2021 20,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 28,8x
Yield 2021 -
Capitalization 580 M 580 M -
Capi. / Sales 2020 6,93x
Capi. / Sales 2021 3,86x
Nbr of Employees 283
Free-Float 54,5%
More Financials
Company
Zynex, Inc. manufactures and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The Company operates through medical devices segment, which include electrotherapy and pain management products. The Company conducts its business through its subsidiaries and the operating subsidiary is Zynex Medical, Inc. (ZMI).... 
More about the company
Notations Surperformance© of Zynex, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ZYNEX, INC.
09/10ZYNEX INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-..
AQ
09/09ZYNEX INC : Results of Operations and Financial Condition, Financial Statements ..
AQ
07/28ZYNEX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
07/28ZYNEX INC : Results of Operations and Financial Condition, Financial Statements ..
AQ
07/17ZYNEX INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure..
AQ
07/13ZYNEX INC : Results of Operations and Financial Condition, Financial Statements ..
AQ
06/10Zynex Shares Up on S&P SmallCap 600 Inclusion
DJ
05/21ZYNEX INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/05ZYNEX INC : Other Events (form 8-K)
AQ
04/28ZYNEX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
04/28ZYNEX INC : Results of Operations and Financial Condition, Financial Statements ..
AQ
02/28ZYNEX : February Investor Presentation & Financial Highlights
PU
02/27ZYNEX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
02/27ZYNEX INC : Results of Operations and Financial Condition, Financial Statements ..
AQ
02/25ZYNEX INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-..
AQ
More news
News in other languages on ZYNEX, INC.

- No features available -

More news
Chart ZYNEX, INC.
Duration : Period :
Zynex, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZYNEX, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 27,35 $
Last Close Price 16,70 $
Spread / Highest target 87,1%
Spread / Average Target 63,8%
Spread / Lowest Target 34,7%
EPS Revisions
Managers
NameTitle
Thomas Sandgaard Chairman, President & Chief Executive Officer
Giuseppe Papandrea Chief Operating Officer
Daniel J. Moorhead Chief Financial Officer
Barry D. Michaels Independent Director
Michael D. Cress Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ZYNEX, INC.112.20%580
THERMO FISHER SCIENTIFIC29.99%167 053
DANAHER CORPORATION34.98%146 961
INTUITIVE SURGICAL, INC.13.97%78 844
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.81.42%58 796
BOSTON SCIENTIFIC CORPORATION-17.43%53 421